Additionally, tirzepatide is not recommended for people with severe gastrointestinal issues like gastroparesis
Link to download (.ppt format): GLP-1 Effectiveness, Mechanisms of Action and Potential, Part 1 of 4 Other sets in this series: GLP-1 Effectiveness, Mechanisms of Action and Potential, Part 2 of 4 GLP-1 Effectiveness, Mechanisms of Action and Potential, Part 3 of 4 GLP-1 Effectiveness, Mechanisms of Action and Potential, Part 4 of 4 See more GLP-1 Agonist Resources.
Because L-arginine has so many critical roles in your body, a deficiency in this amino acid can disrupt cellular and organ function and lead to serious adverse health outcomes
Obesity and diabetes were the strongest predictors, with patients exhibiting obesity having 3.5 times higher odds and those with diabetes having 5.8 times higher odds of being prescribed GLP-1 therapy